Skip to main content
Top
Published in: Sleep and Breathing 3/2015

01-09-2015 | Original Article

What do changes in concentrations of serum surfactant proteins A and D in OSA mean?

Authors: Shao Liang, Nanfang Li, Mulalibieke Heizhati, Xiaoguang Yao, Arikin Abdireim, Yingchun Wang, Zufeiya Abulikemu, Delian Zhang, Guijuan Chang, Jianqiong Kong, Ling Zhou, Jing Hong, Ting Ying, Yongping Zhang

Published in: Sleep and Breathing | Issue 3/2015

Login to get access

Abstract

Purpose

Previous studies have shown that surfactant proteins are affected by oxygen concentration and mechanic stretches, although the alteration of serum surfactant proteins in individuals with obstructive sleep apnea (OSA) is still unclear. Therefore, the aim of this study is to examine whether serum concentrations of surfactant proteins A and D are altered and related to hypopnea index (HI) in OSA.

Methods

This is a cross-sectional study. Consecutive 140 males, suspicious of OSA, were studied. OSA was determined by PSG and polysomnographic data examined. Subjects with HI ≥ 10.1/h were classified as higher HI group and those with HI < 10.1/h as lower HI group. Hs-CRP, HbA1C, and FBG were determined by standard methods and Krebs von den Lungen-6 (KL-6), surfactant protein-A (SP-A), and surfactant protein-D (SP-D) by ELISA.

Results

OSA was diagnosed in 110 patients (78.5 %). Mild, moderate, and severe OSA constitutes 26.4, 27.8, and 24.3 %, respectively. Mean age was 44.6 ± 7.65 years. Subjects with higher HI had lower SP-A (139.54. ± 32.94 vs 158.2 ± 38.9 ng/L, p = 0.005) and SP-D (16.54 ± 3.67 vs 18.10 ± 3.48 ng/L, p = 0.014) compared to those with lower HI. Nocturnal HI was strongly correlated with serum levels of SP-A (r = 0.343, p = 0.012) and SP-D (r = 0.504, p < 0.001) and are inversely associated with circulating SP-A and SP-D levels, even after adjusting for age and body mass index in nonsmoking subjects.

Conclusions

Circulating SP-A and SP-D levels are decreased in some individuals with higher HI in OSA, possibly reflecting severity of hypoxia in OSA.
Literature
1.
go back to reference Li JJ, Appleton SL, Wittert GA et al (2014) The relationship between functional health literacy and obstructive sleep apnea and its related risk factors and comorbidities in a population cohort of men. Sleep 37:571–578PubMedCentralPubMed Li JJ, Appleton SL, Wittert GA et al (2014) The relationship between functional health literacy and obstructive sleep apnea and its related risk factors and comorbidities in a population cohort of men. Sleep 37:571–578PubMedCentralPubMed
2.
go back to reference Sánchez-de-la-Torre M, Campos-Rodriguez F, Barbé F (2013) Obstructive sleep apnoea and cardiovascular disease. Lancet Respir Med 1:61–72CrossRefPubMed Sánchez-de-la-Torre M, Campos-Rodriguez F, Barbé F (2013) Obstructive sleep apnoea and cardiovascular disease. Lancet Respir Med 1:61–72CrossRefPubMed
3.
go back to reference Wasicko MJ, Erlichman JS, Leiter JC (1993) Control of segmental upper airway resistance in patients with obstructive sleep apnea. J Appl Physiol 74:2694–2703PubMed Wasicko MJ, Erlichman JS, Leiter JC (1993) Control of segmental upper airway resistance in patients with obstructive sleep apnea. J Appl Physiol 74:2694–2703PubMed
4.
go back to reference Kimoff RJ, Hamid Q, Divangahi M et al (2011) Increased upper airway cytokines and oxidative stress in severe obstructive sleep apnoea. Eur Respir J 38:89–97CrossRefPubMed Kimoff RJ, Hamid Q, Divangahi M et al (2011) Increased upper airway cytokines and oxidative stress in severe obstructive sleep apnoea. Eur Respir J 38:89–97CrossRefPubMed
5.
go back to reference Aihara K, Oga T, Chihara Y et al (2013) Analysis of systemic and airway inflammation in obstructive sleep apnea. Sleep Breath 17:597–604CrossRefPubMed Aihara K, Oga T, Chihara Y et al (2013) Analysis of systemic and airway inflammation in obstructive sleep apnea. Sleep Breath 17:597–604CrossRefPubMed
6.
go back to reference Sarıman N, Levent E, Cubuk R et al (2011) Bronchial hyperreactivity and airway wall thickening in obstructive sleep apnea patients. Sleep Breath 15:341–350CrossRefPubMed Sarıman N, Levent E, Cubuk R et al (2011) Bronchial hyperreactivity and airway wall thickening in obstructive sleep apnea patients. Sleep Breath 15:341–350CrossRefPubMed
7.
go back to reference Crouch E, Parghi D, Kuan SF et al (1992) Surfactant protein D: subcellular localization in non ciliated bronchiolar epithelial cells. Am J Physiol 263:60–66 Crouch E, Parghi D, Kuan SF et al (1992) Surfactant protein D: subcellular localization in non ciliated bronchiolar epithelial cells. Am J Physiol 263:60–66
8.
go back to reference Kishore U, Greenhough TJ, Waters P et al (2006) Surfactant proteins SP-A and SP-D: structure, function and receptors. Mol Immunol 43:1293–1315CrossRefPubMed Kishore U, Greenhough TJ, Waters P et al (2006) Surfactant proteins SP-A and SP-D: structure, function and receptors. Mol Immunol 43:1293–1315CrossRefPubMed
9.
go back to reference Takahashi H, Fujishima T, Koba H et al (2000) Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med 162:1109–1114CrossRefPubMed Takahashi H, Fujishima T, Koba H et al (2000) Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med 162:1109–1114CrossRefPubMed
10.
go back to reference Ohnishi H, Yokoyama A, Kondo K et al (2002) Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med 165:378–381CrossRefPubMed Ohnishi H, Yokoyama A, Kondo K et al (2002) Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med 165:378–381CrossRefPubMed
11.
go back to reference Stapleton RD, Dixon AE, Parsons PE et al (2010) Acute respiratory distress syndrome network. The association between BMI and plasma cytokine levels in patients with acute lung injury. Chest 138:568–577PubMedCentralCrossRefPubMed Stapleton RD, Dixon AE, Parsons PE et al (2010) Acute respiratory distress syndrome network. The association between BMI and plasma cytokine levels in patients with acute lung injury. Chest 138:568–577PubMedCentralCrossRefPubMed
12.
go back to reference White CW, Greene KE, Allen CB et al (2001) Elevated expression of surfactant proteins in newborn rats during adaptation to hyperoxia. Am J Respir Cell Mol Biol 25:51–59CrossRefPubMed White CW, Greene KE, Allen CB et al (2001) Elevated expression of surfactant proteins in newborn rats during adaptation to hyperoxia. Am J Respir Cell Mol Biol 25:51–59CrossRefPubMed
13.
go back to reference Acarregui MJ, Snyder JM, Mendelson CR (1993) Oxygen modulates the differentiation of human fetal lung in vitro and its responsiveness to cAMP. Am J Physiol 264:465–474 Acarregui MJ, Snyder JM, Mendelson CR (1993) Oxygen modulates the differentiation of human fetal lung in vitro and its responsiveness to cAMP. Am J Physiol 264:465–474
14.
go back to reference Vives MF, Caspar-Bauguil S, Aliouat EM et al (2008) Hypobaric hypoxia-related impairment of pulmonary surfactant proteins A and D did not favour Pneumocystis carinii Frenkel 1999 growth in non-immunocompromised rats. Parasite 15:53–64CrossRefPubMed Vives MF, Caspar-Bauguil S, Aliouat EM et al (2008) Hypobaric hypoxia-related impairment of pulmonary surfactant proteins A and D did not favour Pneumocystis carinii Frenkel 1999 growth in non-immunocompromised rats. Parasite 15:53–64CrossRefPubMed
15.
go back to reference Wirtz HR, Dobbs LG (1990) Calcium mobilization and exocytosis after one mechanical stretch of lung epithelial cells. Science 250:1266–1269CrossRefPubMed Wirtz HR, Dobbs LG (1990) Calcium mobilization and exocytosis after one mechanical stretch of lung epithelial cells. Science 250:1266–1269CrossRefPubMed
16.
go back to reference Arold SP, Bartolák-Suki E, Suki B (2009) Variable stretch pattern enhances surfactant secretion in alveolar type II cells in culture. Am J Physiol Lung Cell Mol Physiol 296:574–581CrossRef Arold SP, Bartolák-Suki E, Suki B (2009) Variable stretch pattern enhances surfactant secretion in alveolar type II cells in culture. Am J Physiol Lung Cell Mol Physiol 296:574–581CrossRef
17.
go back to reference Sanchez-Esteban J, Cicchiello LA, Wang Y et al (2001) Mechanical stretch promotes alveolar epithelial type II cell differentiation. J Appl Physiol 91:589–595PubMed Sanchez-Esteban J, Cicchiello LA, Wang Y et al (2001) Mechanical stretch promotes alveolar epithelial type II cell differentiation. J Appl Physiol 91:589–595PubMed
18.
go back to reference Kuroki Y, Takahashi H, Chiba H et al (1998) Surfactant proteins A and D: disease markers. Biochim Biophys Acta 1408:334–345CrossRefPubMed Kuroki Y, Takahashi H, Chiba H et al (1998) Surfactant proteins A and D: disease markers. Biochim Biophys Acta 1408:334–345CrossRefPubMed
19.
go back to reference Aihara K, Oga T, Harada Y et al (2011) Comparison of biomarkers of subclinical lung injury in obstructive sleep apnea. Respir Med 105:939–945CrossRefPubMed Aihara K, Oga T, Harada Y et al (2011) Comparison of biomarkers of subclinical lung injury in obstructive sleep apnea. Respir Med 105:939–945CrossRefPubMed
20.
go back to reference Digeronimo RJ, Mustafa SB, Ryan RM et al (2007) Mechanical ventilation down-regulates surfactant protein A and keratinocyte growth factor expression in premature rabbits. Pediatr Res 62:277–282CrossRefPubMed Digeronimo RJ, Mustafa SB, Ryan RM et al (2007) Mechanical ventilation down-regulates surfactant protein A and keratinocyte growth factor expression in premature rabbits. Pediatr Res 62:277–282CrossRefPubMed
21.
go back to reference Bailey TC, Maruscak AA, Petersen A et al (2006) Physiological effects of oxidized exogenous surfactant in vivo: effects of high tidal volume and surfactant protein A. Am J Physiol Lung Cell Mol Physiol 291:703–709CrossRef Bailey TC, Maruscak AA, Petersen A et al (2006) Physiological effects of oxidized exogenous surfactant in vivo: effects of high tidal volume and surfactant protein A. Am J Physiol Lung Cell Mol Physiol 291:703–709CrossRef
22.
go back to reference Reinke C, Bevans-Fonti S, Grigoryev DN et al (2011) Chronic intermittent hypoxia induces lung growth in adult mice. Am J Physiol Lung Cell Mol Physiol 300:266–273CrossRef Reinke C, Bevans-Fonti S, Grigoryev DN et al (2011) Chronic intermittent hypoxia induces lung growth in adult mice. Am J Physiol Lung Cell Mol Physiol 300:266–273CrossRef
23.
go back to reference Orgeig S, Crittenden TA, Marchant C et al (2010) Intrauterine growth restriction delays surfactant protein maturation in the sheep fetus. Am J Physiol Lung Cell Mol Physiol 298:575–583CrossRef Orgeig S, Crittenden TA, Marchant C et al (2010) Intrauterine growth restriction delays surfactant protein maturation in the sheep fetus. Am J Physiol Lung Cell Mol Physiol 298:575–583CrossRef
24.
go back to reference Qiu L, Deng C, Fu Z et al (2011) The role of transforming growth factors beta1 and beta3 in pre- and post-natal pulmonary surfactant development. Cell Biol Int 35:287–292CrossRefPubMed Qiu L, Deng C, Fu Z et al (2011) The role of transforming growth factors beta1 and beta3 in pre- and post-natal pulmonary surfactant development. Cell Biol Int 35:287–292CrossRefPubMed
25.
go back to reference Romero-Corral A, Caples SM, Lopez-Jimenez F et al (2010) Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest 137:711–719PubMedCentralCrossRefPubMed Romero-Corral A, Caples SM, Lopez-Jimenez F et al (2010) Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest 137:711–719PubMedCentralCrossRefPubMed
26.
go back to reference Babb TG, Wyrick BL, DeLorey DS et al (2008) Fat distribution and end-expiratory lung volume in lean and obese men and women. Chest 134:704–711CrossRefPubMed Babb TG, Wyrick BL, DeLorey DS et al (2008) Fat distribution and end-expiratory lung volume in lean and obese men and women. Chest 134:704–711CrossRefPubMed
27.
go back to reference Watson RA, Pride NB (2005) Postural changes in lung volumes and respiratory resistance in subjects with obesity. J Appl Physiol 98:512–517CrossRefPubMed Watson RA, Pride NB (2005) Postural changes in lung volumes and respiratory resistance in subjects with obesity. J Appl Physiol 98:512–517CrossRefPubMed
28.
go back to reference Mazur W, Toljamo T, Ohlmeier S et al (2011) Elevation of surfactant protein A in plasma and sputum in cigarette smokers. Eur Respir J 38:277–284CrossRefPubMed Mazur W, Toljamo T, Ohlmeier S et al (2011) Elevation of surfactant protein A in plasma and sputum in cigarette smokers. Eur Respir J 38:277–284CrossRefPubMed
29.
go back to reference Ilumets H, Mazur W, Toljamo T et al (2011) Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction. BMC Pulm Med 19:11–19 Ilumets H, Mazur W, Toljamo T et al (2011) Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction. BMC Pulm Med 19:11–19
30.
go back to reference Van Miert E, Sardella A, Bernard A (2011) Biomarkers of early respiratory effects in smoking adolescents. Eur Respir J 38:1287–1293CrossRefPubMed Van Miert E, Sardella A, Bernard A (2011) Biomarkers of early respiratory effects in smoking adolescents. Eur Respir J 38:1287–1293CrossRefPubMed
Metadata
Title
What do changes in concentrations of serum surfactant proteins A and D in OSA mean?
Authors
Shao Liang
Nanfang Li
Mulalibieke Heizhati
Xiaoguang Yao
Arikin Abdireim
Yingchun Wang
Zufeiya Abulikemu
Delian Zhang
Guijuan Chang
Jianqiong Kong
Ling Zhou
Jing Hong
Ting Ying
Yongping Zhang
Publication date
01-09-2015
Publisher
Springer Berlin Heidelberg
Published in
Sleep and Breathing / Issue 3/2015
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-014-1106-6

Other articles of this Issue 3/2015

Sleep and Breathing 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.